SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/14/22 Lantronix Inc. 8-K:5,7 9/13/22 10:186K GlobalOne Filings Inc/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 27K 5: R1 Cover HTML 47K 8: XML IDEA XML File -- Filing Summary XML 11K 6: XML XBRL Instance -- lantronix_i8k_htm XML 15K 7: EXCEL IDEA Workbook of Financial Reports XLSX 8K 3: EX-101.LAB XBRL Labels -- ltrx-20220913_lab XML 96K 4: EX-101.PRE XBRL Presentations -- ltrx-20220913_pre XML 63K 2: EX-101.SCH XBRL Schema -- ltrx-20220913 XSD 12K 9: JSON XBRL Instance as JSON Data -- MetaLinks 25± 32K 10: ZIP XBRL Zipped Folder -- 0001683168-22-006392-xbrl Zip 15K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i September 13, 2022
(Exact Name of Registrant as Specified in Charter)
i Delaware | i 1-16027 | i 33-0362767 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) | ||
i 48
Discovery, i Suite
250 i Irvine, i California i 92618 | ||||
(Address of Principal Executive Offices, including zip code) | ||||
Registrant’s telephone number, including area code: ( i 949) i 453-3990 | ||||
Not Applicable | ||||
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class | Trading Symbol | Name of each exchange on which registered | |
i Common Stock, $0.0001 par value | i LTRX | The i Nasdaq Stock Market LLC | |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. ☐
C:
|
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On September 13, 2022, Margaret A. Evashenk, a member of the Board of Directors (the “Board”) of Lantronix, Inc. (the “Company”), notified the Company of her decision not to stand for re-election at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”). Ms. Evashenk’s decision not to stand for re-election at the Annual Meeting was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Ms. Evashenk currently serves as Chair of the Compensation Committee and as a member of the Audit and Corporate Governance & Nominating Committees, and will continue to serve in these capacities until the Annual Meeting.
Item 7.01 | Regulation FD Disclosure. |
On September 14, 2022, the Board appointed Ms. Evashenk to the Company’s Advisory Board, effective immediately following the Annual Meeting.
In accordance with General Instruction B.2 of Form 8-K, the information furnished under this Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
C:
C: 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: September 14, 2022 | LANTRONIX, INC. | ||
By: | /s/ Jeremy Whitaker | ||
Chief Financial Officer |
C:
3 |
C:
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 9/14/22 | None on these Dates | ||
For Period end: | 9/13/22 | |||
List all Filings |